Telangana Drug Controller issues alert against drugs by Meg Lifesciences

Published On 2024-03-08 12:22 GMT   |   Update On 2024-03-08 12:22 GMT

In a significant move to curb the menace of falsified drugs, the Drugs Control Administration, Telangana, has issued a Spurious Drug Alert and Stop Use Notice for all drugs claiming to be manufactured by 'Meg Lifesciences'.

Telangana Drug Control Administration has become aware that certain drugs claimed on the label as manufactured by 'Meg Lifesciences, Khasara No. 47/5, Palli Gaon, Distt. Sirmour, 173 001' are being circulated in the market after the recent raid conducted by the administration. Stocks worth Rs. 33.35 lakhs seized in the raid claimed to be manufactured by Meg Lifesciences. Cases have been registered against several offenders involved in this spurious drugs racket.

For more information, click on the link below:

Chalk Powder Instead Of Medicines: Telangana Drug Controller Issues Alert Against Drugs By Meg Lifesciences



Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News